Literature DB >> 3097144

Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.

W W Hancock, W A Muller, R S Cotran.   

Abstract

Expression of receptors for IL 2 was believed initially to be restricted to T cells after their activation by IL 1 and antigen. However, recently IL 2 receptors (IL 2R) were demonstrated on activated B cells by using an anti-IL 2R monoclonal antibody (anti-Tac). In this study, we examined the capacity of cultured human alveolar macrophages, blood monocytes, and myelomonocytic (HL-60) or monoblast (U937) cell lines to bind three different anti-IL 2R monoclonal antibodies before or after stimulation with the monocyte-activating agents IFN-gamma, LPS, phorbol ester, or lymphokine-containing conditioned medium. For each of the four cell populations examined, resting unstimulated cells bound little or no anti-IL 2R antibody, as shown independently by quantitative cell binding assay and by immunoperoxidase labeling. By contrast, incubation with recombinant IFN-gamma, conditioned medium, or to a lesser extent, native or recombinant IL 2 itself, resulted in a significant enhancement of anti-IL 2 receptor monoclonal antibody binding by all four populations, whereas LPS, PMA, or IL 1 had no effect. In addition, membrane binding of anti-Tac antibody, similar to that seen after stimulation of normal lung macrophages with IFN-gamma, was detected by using macrophages obtained by bronchoalveolar lavage of five patients with active pulmonary sarcoidosis. These findings are consistent with the expression of a functional IL 2R on activated cells of the monocyte lineage, since anti-Tac binding to IFN-gamma-treated HL-60 cells was inhibited by addition of excess IL-2; specific binding of anti-IL 2 monoclonal antibodies was detected in the presence of exogenous IL 2; and a 50 to 55 kD molecule was immunoprecipitated from both activated lung macrophages and T lymphoblasts by using anti-Tac antibody. We conclude that human mononuclear phagocytes can be induced by lymphokines to express IL 2R, and that such IL 2R+ macrophages can be detected in vivo during inflammation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3097144

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.

Authors:  J E Crabtree; L D Juby; R V Heatley; A J Lobo; D W Bullimore; A T Axon
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

3.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

4.  Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis.

Authors:  Z Toossi; J R Sedor; J P Lapurga; R J Ondash; J J Ellner
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

5.  In vivo biology of recombinant interleukin-2 infusion in sheep: cardiopulmonary manifestations of an intravascular immune-inflammatory response.

Authors:  G J Jesmok; R A Gunther
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

6.  Mononuclear phagocyte system of human Peyer's patches: an immunohistochemical study using monoclonal antibodies.

Authors:  Y R Mahida; S Patel; D P Jewell
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge.

Authors:  J E Crabtree; R V Heatley; L D Juby; P D Howdle; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

8.  Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies.

Authors:  D Delia; C Traversari; D Ballinari; G Cattoretti; E Fontanella; N Polli; G Della Porta
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

9.  Interleukin 2 receptor expression by macrophages in inflammatory bowel disease.

Authors:  Y R Mahida; S Patel; K Wu; D P Jewell
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

10.  Interleukin-2 receptors on rat eosinophils in adjuvant arthritis.

Authors:  S C Meacock; D R Brandon; W Smith
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.